Effects of oral glutamine supplementation on children with solid tumors receiving chemotherapy

Pediatric Hematology and Oncology

Volumn 23, Issue 4, 2006, Pages 277-285

  Okur, Arzu ^a,b   Ezgü, Fatih Süheyl ^a   Tümer, Leyla ^a   Cinasal, Gülden ^a   Oguz, Aynur ^a   Hasanoglu, Alev ^a   Karadeniz, Ceyda ^a  

^a GAZI UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Glutamine; Immunonutrition; Malignancy

Indexed keywords

ALBUMIN; BLEOMYCIN; CARMUSTINE; CISPLATIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DACTINOMYCIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; GLUTAMINE; HEMOGLOBIN; IFOSFAMIDE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MELPHALAN; METHOTREXATE; PREALBUMIN; PROTEIN; TRANSFERRIN; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ALBUMIN BLOOD LEVEL; ANTIBIOTIC THERAPY; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLEMENT BLOOD LEVEL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG MEGADOSE; DRUG USE; FEVER; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN DETERMINATION; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOLOGICAL PARAMETERS; LEUKOCYTE COUNT; NEUTROPHIL COUNT; NUTRITIONAL PARAMETERS; SOLID TUMOR; STOMATITIS; THERAPY EFFECT; TRANSFERRIN BLOOD LEVEL;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BODY WEIGHTS AND MEASURES; CHILD; CHILD, PRESCHOOL; FEMALE; GLUTAMINE; HUMANS; IMMUNE SYSTEM; IMMUNOLOGIC FACTORS; INFANT; MALE; NEOPLASMS; NUTRITIONAL STATUS; PARENTERAL NUTRITION; TREATMENT OUTCOME;

EID: 33646356775     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.1080/08880010600628926     Document Type: Article

References (38)

1. Magrath IA. Malignant non-Hodgkin's lymphomas in children. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology, ed 4. Philadelphia: Lippincott Williams; 2002:661-696.
2. Bergstrom J, Furst P, Noree LO, et al. Intracelluler free amino acid concentration in human muscle tissue. J Appl Physiol. 1974;36:693-697.
3. Lacey J, Wilmore D. Is glutamine a conditionally essential amino acid? Nutr Rev. 1990;48:297-309.
4. Bartlett D, Charland S, Torosian M. Effect of glutamine on tumor and host growth. Ann Surg Oncol. 1995;2:71-76.
5. Klimberg V, Souba W, Salloum R, et al. Glutamine-enriched diets support muscle glutamine metabolism without stimulating tumor growth. J Surg Res. 1990;48:319-323.
6. Van Der Hulst R, Kreel B, Von Meyenfeldt M, et al. Glutamine and the preservation of gut integrity. Lancet. 1993;341:1363-1365.
7. Shewchuk L, Baracos V, Field C. Dietary L-glutamine supplementation reduces the growth of the morris hepatoma 7777 in exercise-trained and sedentary rats. J Nutr. 1997;127:158-166.
8. Piccirillo N, Matteis S, Laurenti L, et al. Glutamine enriched parenteral nutrition after autologous peripheral blood stem cell transplantation effects on immune reconstitution and mucositis. Haematologica. 2003;88:192-200.
9. Anderson PM, Schroeder G, Skubitz KM. Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy. Cancer. 1998;83:1433-1439.
10. Senkal M, Zumtobel V, Bauer KH, et al. Outcome and cost-effectiveness of perioperative enteral immunonutrition in patients undergoing elective upper gastrointestinal tract surgery: a prospective randomized study. Arch Surg. 1999;134:1309-1316.
11. Senkal M, Mumme A, Eickhoff U, et al. Early postoperative enteral immunonutrition: clinical outcome and cost-comparison analysis in surgical patients. Crit Care Med. 1997;25:1489-1496.
12. Dawson B, Trapp RG. Comparing means with the Wilcoxon rank sum test. In: Basic & Clinic Biostatistics, ed 3. New York: Lange, McGraw-Hill; 2001:141-144.
13. Dawson B, Trapp RG. The Wilcoxon signed rank test for the mean difference. In: Basic & Clinic Biostatistics, ed 3. New York: Lange, McGraw-Hill; 2001:122-124.
14. Dawson B, Trapp RG. Small Expected frequencies & Fisher's exact test. In: Basic & Clinic Biostatistics, ed 3. New York: Lange, McGraw-Hill; 2001:149-151.
15. Rodwell VW. Biosynthesis of the nutritionally nonessential amino acids. In: Murray RK, Granner DK, Mayes PA, Rodwell VW, eds. Harper's Biochemistry, ed 25th. New York: Lange, McGraw-Hill; 2000:308-309.
16. van Acker BA, von Meyenfeldt MF, van der Hulst RR, et al. Glutamine: the pivot of our nitrogen economy? J Parent Enteral Nutr. 1999;23:45-48.
17. Newsholme P, Curi R, Pithon Curi TC, et al. Glutamine metabolism by lymphocytes, macrophages and neutrophils:its importance in health and disease. J Nutr Biochem. 1999;10:316-324.
18. Karinch AM, Pan M, Lin CM, et al. Glutamine metabolism in sepsis and infection. J Nutr Suppl. 2001;131:2525-2531.
19. Fox AD, Kripke SA, Berman JR, et al. Reduction of the severity of enterocolitis by glutamine supplemented enteral diets. Surg Forum. 1987;38:43-44.
20. Burke D, Alverdy JC, Aays E, et al. Glutamine supplemented total parenteral nutrition improves gut immune function. Arch Surg. 1989;124:1396-1399.
21. Jacobs DO, Evans DA, O'Dwyer ST. Disparate effects of 5-fluorouracil on the ileum and colon of enterally fed rats with protection by dietary glutamine. Surg Forum. 1987;38:45-46.
22. Smith RJ. Glutamine supplemented nutrition. J Parent Enteral Nutr. 1997;21:183-184.
23. Clifford L. Laboratory assessment of nutritional status. In: Walker, Watkins, eds. Nutrition in Pediatrics. ed 2. BC Decker: Hamilton, ON; 1997:29-43.
24. Kouznetsova L, Bijlsma P, van Leeuwen P, et al. Glutamine reduces phorbol-12,13-dibutyrate-induced macromolecular hyperpermeability in HT-29CI.19A intestinal cells. JPEN. 1999;23:136-139.
25. Ziegler TR, Bye RL, Persinger RL, et al. Effects of glutamine enriched intravenous nutrition on circulating lymphocytes after bone marrow transplantation: a pilot study. Am J Med Sci. 1998;315:4-10.
26. Chang WK, Yang KD, Shaio MF. Lymphocyte proliferation modulated by glutamine involved in the endogenous redox reaction. Clin Exp Immunol. 1999;117:482-488.
27. Ziegler TR, Young LS, Benfell K, et al. Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation: a randomized double-blind, controlled study. Ann Intern Med. 1992;116:821-828.
28. Schloerb PR, Amare M. Total parenteral nutrition with glutamine in bone marrow transplantation and other clinical applications (a randomized double-blind study). J Parenter Enteral Nutr. 1993;17:407-413.
29. Dimopoulos MA, Papadimitriou C, Hamilos G, et al. Treatment of ovarian germ cell tumors with a 3-day bleomycin, etoposide, and cisplatin regimen: a prospective multicenter study. Gynecol Oncolf. 2004;95:695-700.
30. Reiter A, Schrappe M, Yakisan E, et al. NHL-BFM 90 therapy study in treatment of malignant non- Hodgkin's lymphoma in children and adolescents, 3: an intermediate term analysis of the B-NHL/B-ALL. Klin Padiatr. 1994;206:242-252.
31. Girouard C, Dufresne J, Imrie K, et al. Salvage chemotherapy with mini-BEAM for relapsed or refractory non-Hodgkin's lymphoma prior to autologous bone marrow transplantation. Ann Oncol. 1997;8:675-680.
32. Laskar S, Gupta T, Vimal S, et al. Consolidation radiation after complete remission in Hodgkin's disease fallowing six cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy: is there a need? J Clin Oncol. 2204;22:62-68.
33. Kaneko M, Nishihira H, Mugishima H, et al. Stratification of treatment of stage 4 neuroblastoma patients based on N-myc amplification status. Study Group of Japan for Treatment of Advanced Neuroblastoma, Tokyo, Japan. Med Pediatr Oncol. 1998;31:1-7.
34. Greenberg M, Burnweit C, Filler R, et al. Preoperative chemotherapy for children with Wilms' tumor. J Pediatr Surg. 1991;26:949-953.
35. Crews KR, Liu T, Rodriguez-Galindo C, et al. High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma. Cancer. 2004;100:1724-1733.
36. Miser JS, Krailo MD, Tarbell NJ, et al. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide. A Children's Cancer Group and Pediatric Oncology Group study. J Clin Oncol. 2004;22:2873-2876.
37. Chiu SN, Ni YH, Lu MY, et al. A trend of improved survival of childhood hepatoblastoma treated with cisplatin and doxorubicin in Taiwanese children. Pediatr Surg Int. 2003;19:593-597.
38. Mottl H, Bajciova V, Nemec S, Al Shemmari S, Al Awadi S. High survival rate in childhood non-Hodgkin lymphoma without CNS involvement: results of BFM-95 study in Kuwait. Pediatr Hematol Oncol. 2003;20:103-110.